The Trans-Pacific Partnership has several issues about the United States in regards to the control with limiting /minimizing regulation, helping corporate interest on an international level, and inflicting fiercer standards of Intellectual Property (IP). Those arguments show its validity in various aspects of the agreement and there is no coincidence that the U.S. led and pushed for the proposals. However, while the United States proposes for the reformation of international laws it incorporates Australia, Brunei, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, and Vietnam as signatory nations that fall under U.S. global domination. Throughout the research I could not find much discussion about how the public health and Intellectual Property (IP) display traces of neoliberal influence. My objective of this paper is to discuss how the U.S. uses the Trans-Pacific Partnership agreement as a strategic element to increase their power in different areas by connecting three of their TPP proposals.
To further understand and reach my objective, I have formatted my paper into three main sections. In the first section, I present the topic of pharmaceutical companies. In the first part of the section are the four provisions that would involve patents and how it would begin the creation of monopolistic companies. I then mention on how the pharmaceutical companies would then have the access to increase drug prices and the consequences it has on consumers. In my second I focus on HIV/AIDS drugs and provide the problem and how it has affected developing countries. In my last section I focus on food safety regulations. I explain the three ways that the international markets have been used as dominating consumer acceptance. I...
... middle of paper ...
...Web. 15 May 2014.
Friel, Sharon, et al. "A New Generation Of Trade Policy: Potential Risks To Diet-Related Health From The Trans Pacific Partnership Agreement." Globalization & Health 9.1 (2013): 1-15. Academic Search Complete. Web. 15 May 2014.
Lewis, Meredith Kolsky. "The Trans-Pacific Partnership: New Paradigm Or Wolf In Sheep's Clothing?" Boston College International & Comparative Law Review 34.1 (2011): 27-52. Academic Search Complete. Web. 15 May 2014.
Löfgren, Hans. "The Trans-Pacific Partnership Agreement: a threat to affordable medicines and public health." Southern Med Review Dec. 2011: 2. Academic Search Complete. Web. 15 May 2014.
Lopert, Ruth, and Deborah Gleeson. "The High Price Of 'Free' Trade: U.S. Trade Agreements And Access To Medicines." Journal Of Law, Medicine & Ethics 41.1 (2013): 199-223. Consumer Health Complete - EBSCOhost. Web. 15 May 2014.
In America today, many people are in need of medical help. In fact,the Federal Trade Commission estimates that 75% of the population complain of physical problems (Federal Trade Commission 9). They complain, for example, of fatigue, colds, headaches, and countless other "ailments." When these symptoms strike, 65% purchase over-the counter, or OTC, drugs. In order to take advantage of this demand, five billion dollars is spent by the pharmaceutical industry on marketing each year . This marketing, usually in the form of advert...
CETA as a trade pact benefits certain Canadian industry’s sectors. One of them is the Food industry which yearly will gain over 1, 5 billion dollars from export to Europe (Ryan, 2014, p. 24-26). European Union will allow Canadian beef to enter the Union without any tariffs (Kimantas, 2014, p.11). It is expected more than 35, 000 tonnes to be exported, thus increasing the initial amount of beef that is originally produced in Canada (Kimantas, 2014, p.11). In addition, the Canada’s Hilton quota, that means a limited amount of beef, can be increased; therefore the amount of beef that have chemicals or contains GMO imported in European Union also will be increased, although many European environmentalists are against such change (Kerr, 2011, p.667). Pork producers will also ...
Yu, Winnie and Joel Hay. 1999. “Drug Patents and Prices: Can we Achieve Better Outcomes?” Measuring the Prices of Medical Treatments. Pages 27-28.
It is said that name-brand prescription drugs in Canada cost approximately 40% less than they do in America. But it is illegal for the transport of drugs from Canada to America. Why? It is because Pharmaceuticals are simply greedy and prey on victims that are in need of their products to survive. It makes it hard for large households on a budget to purchase drugs to keep healthy. The way pharmaceutical companies look at their clients is like this: It is a life or death situation for them so the customers have to buy it in order to survive. According to the annual Fortune 500 survey, the pharmaceutical industry, expectedly, made it at the top of the list of the most profitable. The top seven pharmaceutical companies took in more profit-money than the top seven media companies, the top seven airline companies, the top seven oil companies, and the top seven car manufacture companies. (…cost so much, CNN) The profits of pharmaceutical companies are outrageous and extreme. There are many reasons to why these companies are greedily taking advantage of customers. The number one reason is because people who are need of these prescriptions have no other choice but to purchase them.
In the article Escape from the Western Diet, Michael Pollan points out the many different concepts that contribute to obesity and disease in so many individuals and how breaking what he calls the “Western Diet” can curtail these issues. A western diet is one containing saturated fats, red meats, and junk food. Pollan advocates “we should simply avoid any food that has been processed to such an extent that it is more the product of industry than of nature,” (Pollan 424). People who are exposed to this diet made up of mostly processed, fatty foods are more prone to obesity, diabetes, heart disease and so forth. He puts blame on food and health industries for the production and consumption of these foods: the food industry promotes these disease
Pang, T. (2004, October ). Globalization and Risks to health . Retrieved 4 22, 2014, from National Library of Medicine: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1299207/
Kinney, Eleanor D. "Realization of the International Human Right to Health in an Economically Integrated North America." Journal of Law, Medicine & Ethics 37.4 (2009): 807-818. Academic Search Premier. EBSCO. Web. 15 Mar. 2011.
The United States spends more per capita on health care than any other country, with the percentage of gross domestic product dedicated to health care doubling from 9% in 1980 to 18% in 2011(Kesselheim,). One of the contributors to health care inflation is prescription drugs. Pharmaceuticals account for about 10% of total health care costs, spending on pharmaceuticals is poised to swell in upcoming years as a result of the increasing prices of complex specialty medicines (Kesselheim). Name brand drugs are going to have to be set at higher prices, in order for pharmaceutical companies to receive a profit. If the patient has full coverage on a medication, there is a greater chance that medication will be taken, although it may not be
The social problem surrounding the pharmaceutical industry can only be looked at through system blame. People see the good that the medication is doing for themselves and their famil...
Missoni, E. (2013). Understanding the impact of global trade liberalization on health systems pursuing universal health coverage. Value in Health, 16, S14-S18
Rising prescription drug prices are driving nearly two million Americans to cross international borders to seek necessary medications. Some are physically venturing into Canada and Mexico for the pharmaceuticals, while others are turning to mail-order pharmacies via the Internet. Purchasing prescriptions from Canada and Mexico is markedly less expensive than buying them at your local pharmacy or from a U.S. online pharmacy; however, the question is why? The why is what economists call price discrimination. It means charging different prices to different buyers of the same product. Price discrimination works in the drug industry because drugs are very expensive to develop, but inexpensive to manufacture. American consumers are exhauste...
"Global Dietary Changes Threaten Health." World Health Federation. Medtronic Foundation, n.d. Web. 30 Nov. 2013. .
Vollrath, T. L. (1991). U.S. trade in competitive world markets. FoodReview, 14(1), 26. Retrieved from EBSCOhost.
The cost of US health care has been steadily increasing for many years causing many Americans to face difficult choices between health care and other priorities in their lives. Health economists are bringing to light the tradeoffs which must be considered in every healthcare decision (Getzen, 2013, p. 427). Therefore, efforts must be made to incite change which constrains the cost of health care without creating adverse health consequences. As the medical field becomes more business oriented, there will be more of a shift in focus toward the costs and benefits, which will make medicine more like the rest of the economy (Getzen, 2013, p. 439).
Frank, Barney (1999), “The Correct Approach to Globalization,” Congressional Record, [http://apcentral.collegeboard.com/apc/public/repository/ap05_comp_govpol_glob_42253.pdf], accessed 17 May 2012.